What we have learned for the future about COVID-19 and healthcare management of it?


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
22 07 2020
Historique:
received: 17 07 2020
accepted: 21 07 2020
entrez: 2 2 2021
pubmed: 3 2 2021
medline: 12 2 2021
Statut: epublish

Résumé

COVID-19 is a current global pandemic. However, comprehensive global data analyses for its healthcare management are lacking. In this study we have researched through published scientific articles and international health care  guidelines to find out actually about our knowledge for this new pandemic from SARS-CoV-2 and related COVID-19 disease that emerged from December 2019 in China in order to better manage this health emergency. The pathogens represented by microorganisms (bacteria, mycetes or viruses) show their effect after days and are responsible for epidemics/pandemics as dangerous as the greater their possibility of transmission, especially by inhalation, and therefore their infectivity. The appearance of new pathogenic viruses for humans such as the COVID -19, which previously were found only in the animal world occurs through the spillover (is the third documented of an animal coronavirus to humans), it is thought that it could also be the same also for the origin of this virus. Furthermore, the trend of this pandemic in one of the countries most affected by Italy after China was also considered.

Sections du résumé

BACKGROUND AND AIM OF THE WORK
COVID-19 is a current global pandemic. However, comprehensive global data analyses for its healthcare management are lacking.
METHODS
In this study we have researched through published scientific articles and international health care  guidelines to find out actually about our knowledge for this new pandemic from SARS-CoV-2 and related COVID-19 disease that emerged from December 2019 in China in order to better manage this health emergency.
RESULTS
The pathogens represented by microorganisms (bacteria, mycetes or viruses) show their effect after days and are responsible for epidemics/pandemics as dangerous as the greater their possibility of transmission, especially by inhalation, and therefore their infectivity.
CONCLUSIONS
The appearance of new pathogenic viruses for humans such as the COVID -19, which previously were found only in the animal world occurs through the spillover (is the third documented of an animal coronavirus to humans), it is thought that it could also be the same also for the origin of this virus. Furthermore, the trend of this pandemic in one of the countries most affected by Italy after China was also considered.

Identifiants

pubmed: 33525232
doi: 10.23750/abm.v91i4.10253
pmc: PMC7927466
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2020126

Références

Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
J Am Acad Dermatol. 2020 Jul;83(1):280-285
pubmed: 32305439
Acta Biomed. 2020 May 11;91(2):222-223
pubmed: 32420951
Acta Biomed. 2020 May 11;91(2):236-238
pubmed: 32420957
J Med Virol. 2020 Apr;92(4):433-440
pubmed: 31967321
N Engl J Med. 2003 May 15;348(20):1967-76
pubmed: 12690091
Anaesthesiol Intensive Ther. 2020;52(1):34-41
pubmed: 32191830
Int J Occup Environ Med. 2020 Mar 30;11(3):151-152
pubmed: 32225178
Cell Mol Life Sci. 2021 Feb;78(4):1501-1522
pubmed: 32623480
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7173-7191
pubmed: 32633414
Lancet Neurol. 2020 Sep;19(9):767-783
pubmed: 32622375
J Clin Microbiol. 2010 Sep;48(9):3132-7
pubmed: 20631100
ACS Nano. 2020 Apr 28;14(4):3822-3835
pubmed: 32223179
Int J Stroke. 2020 Jun;15(4):385-389
pubmed: 32310015
J Med Virol. 2020 Apr;92(4):455-459
pubmed: 31994738
Acta Biomed. 2020 Jun 20;91(6-S):5-8
pubmed: 32573501
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):927
pubmed: 32585601
Acta Biomed. 2020 May 11;91(2):195-198
pubmed: 32420944

Auteurs

Ioannis Alexandros Charitos (IA)

Regional Emergency Service, National Poisoning Center, University Hospital of Foggia. alexanestesia@hotmail.com.

Raffaele Del Prete (R)

Department of Interdisciplinary Medicine, Microbiology and Virology Unit, University of Bari Aldo Moro, Bari, Italy. raffaele.delprete@uniba.it.

Francesco Inchingolo (F)

Department of Interdisciplinary Medicine, Section of Dentistry, University of Bari Aldo Moro, Bari, Italy. francesco.inchingolo@uniba.it.

Adriana Mosca (A)

Department of Interdisciplinary Medicine, Microbiology and Virology Unit, University of Bari Aldo Moro, Bari, Italy. adriana.mosca@uniba.it.

Domenico Carretta (D)

Department of Interdisciplinary Medicine, Section of Dentistry, University of Bari Aldo Moro, Bari, Italy. sorrisoebenessere@pec.it.

Andrea Ballini (A)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari "Aldo Moro", Campus Universitario "Ernesto Quagliariello", Bari, Italy; Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy. andrea.ballini@uniba.it.

Luigi Santacroce (L)

Department of Interdisciplinary Medicine, Microbiology and Virology Unit, University of Bari Aldo Moro, Bari, Italy. luigi.santacroce@uniba.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH